Parsonex Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.35M Buy
4,628
+292
+7% +$345K 4% 8
2026
Q2
$5.2M Buy
4,336
+106
+3% +$108K 4.52% 6
2026
Q1
$3.89M Sell
4,230
-286
-6% -$290K 3.8% 10
2025
Q4
$4.85M Buy
4,516
+342
+8% +$327K 3.09% 10
2025
Q3
$3.18M Buy
4,174
+1,067
+34% +$794K 2.17% 15
2025
Q2
$2.42M Buy
+3,107
New +$2.41M 2.02% 15

Other funds holding LLY

Parsonex Advisory Services's LLY Position: Q3 2026 in Review

Parsonex Advisory Services increased its Eli Lilly (LLY) stake by 6.7% in Q3 2026, buying an estimated $345K and bringing the position to 4,628 shares worth $5.35M. The position accounts for 4% of the portfolio, ranked #8.

Parsonex Advisory Services first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Parsonex Advisory Services held 4,628 shares of Eli Lilly worth $5.35M as of Q3 2026.
  • Parsonex Advisory Services bought 292 Eli Lilly shares in Q3 2026, an estimated $345K.
  • Eli Lilly made up 4% of Parsonex Advisory Services's portfolio in Q3 2026, its #8 holding.
  • Parsonex Advisory Services first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Parsonex Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.